참고문헌
- Armstrong GT : Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 14 : 298-303, 2010 https://doi.org/10.1016/j.ejpn.2009.12.006
- Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, et al. : Feasibility and response to induction chemotherapy intensified with highdose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22 : 4881-4887, 2004 https://doi.org/10.1200/JCO.2004.12.126
- Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ : Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87 : 46-52, 2013 https://doi.org/10.1016/j.ijrobp.2013.04.030
- Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al. : Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 27 : 2339-2355, 2009 https://doi.org/10.1200/JCO.2008.21.1953
- Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, et al. : Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer 50 : 312-318, 2008 https://doi.org/10.1002/pbc.21307
- Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, et al. : Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45 : 137-145, 1999 https://doi.org/10.1016/S0360-3016(99)00177-7
- Kortmann RD, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V, et al. : Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46 : 269-279, 2000 https://doi.org/10.1016/S0360-3016(99)00369-7
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97-109, 2007 https://doi.org/10.1007/s00401-007-0243-4
- Marachelian A, Butturini A, Finlay J : Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors. Bone Marrow Transplant 41 : 167-172, 2008 https://doi.org/10.1038/sj.bmt.1705953
- Mason WP, Grovas A, Halpern S, Dunkel IJ, Garvin J, Heller G, et al. : Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16 : 210-221, 1998 https://doi.org/10.1200/JCO.1998.16.1.210
- Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, et al. : Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cisretinoic acid: a children's oncology group study. J Clin Oncol 27 : 1007- 1013, 2009 https://doi.org/10.1200/JCO.2007.13.8925
- Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U : Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51 : 110-117, 2008 https://doi.org/10.1002/pbc.21530
- Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, et al. : Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 70 : 782-787, 2008 https://doi.org/10.1016/j.ijrobp.2007.07.2342
- Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, et al. : Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 32 : 1760-1768, 2014 https://doi.org/10.1200/JCO.2013.52.3290
- Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE : Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 16 : 1723-1728, 1998 https://doi.org/10.1200/JCO.1998.16.5.1723
- Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE : Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5 : 399-408, 2004 https://doi.org/10.1016/S1470-2045(04)01507-4
- Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. : Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 : 1572-1582, 2006 https://doi.org/10.1056/NEJMsa060185
- Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. : Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24 : 4202-4208, 2006 https://doi.org/10.1200/JCO.2006.06.4980
- Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. : Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 21 : 3255-3261, 2003 https://doi.org/10.1200/JCO.2003.01.202
- Packer RJ, Rood BR, MacDonald TJ : Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg 39 : 60-67, 2003 https://doi.org/10.1159/000071316
- Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, et al. : Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 27 : 135-140, 2012 https://doi.org/10.3346/jkms.2012.27.2.135
- Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM : Intellectual outcome after reduced dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol 19 : 3470-3476, 2001 https://doi.org/10.1200/JCO.2001.19.15.3470
- Sung KW, Lim DH, Son MH, Lee SH, Yoo KH, Koo HH, et al. : Reduceddose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with highrisk medulloblastoma. Neuro Oncol 15 : 352-359, 2013 https://doi.org/10.1093/neuonc/nos304
- Sung KW, Lim DH, Yi ES, Choi YB, Lee JW, Yoo KH, et al. : Tandem highdose chemotherapy and autologous stem cell transplantation for atypical teratoid/rhabdoid Tumor. Cancer Res Treat 48 : 1408-1419, 2016 https://doi.org/10.4143/crt.2015.347
- Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, et al. : Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41 : 727-734, 2005 https://doi.org/10.1016/j.ejca.2004.12.017
- Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, et al. : Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23 : 1491-1499, 2005 https://doi.org/10.1200/JCO.2005.05.187
- Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, et al. : Low-stage medulloblastoma: final analysis of trial comparing standarddose with reduced-dose neuraxis irradiation. J Clin Oncol 18 : 3004- 3011, 2000 https://doi.org/10.1200/JCO.2000.18.16.3004
- Woehrer A, Slavc I, Waldhoer T, Heinzl H, Zielonke N, Czech T, et al. : Incidence of atypical teratoid/rhabdoid tumors in children: a populationbased study by the Austrian Brain Tumor Registry, 1996-2006. Cancer 116 : 5725-5732, 2010 https://doi.org/10.1002/cncr.25540
- Wolden SL, Dunkel IJ, Souweidane MM, Happersett L, Khakoo Y, Schupak K, et al. : Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol 21 : 3079-3083, 2003 https://doi.org/10.1200/JCO.2003.11.140
- Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. : Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17 : 832-845, 1999 https://doi.org/10.1200/JCO.1999.17.3.832
- Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD : A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol 113 : 84-88, 2014 https://doi.org/10.1016/j.radonc.2014.07.003
피인용 문헌
- 양성자 치료: 융복합 첨단 암 치료로서의 임상적 유효성에 대한 문헌 고찰 vol.9, pp.10, 2018, https://doi.org/10.15207/jkcs.2018.9.10.191
- BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors vol.12, pp.1, 2020, https://doi.org/10.3390/cancers12010066
- Influence of Target Location, Size, and Patient Age on Normal Tissue Sparing- Proton and Photon Therapy in Paediatric Brain Tumour Patient-Specific Approach vol.12, pp.9, 2020, https://doi.org/10.3390/cancers12092578